Skip to content
value.today

Dermira, Inc.

Total raised
$113 M
5 rounds on record
Latest round
$1 M
Dec 2018
First round on record
Aug 2011
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Dermira, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2018$1 MNo. 5Under $2 million

Dermira, Inc.: Raise no. 5, Dec 2018

Investors in this round

1 investor had bought by the notice of Dec 31, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Dermira, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew L. Guggenhime · Executive Officer
  • Christopher M. Griffith · Executive Officer
  • Christopher R. Horan · Executive Officer
  • Eugene A. Bauer · Executive Officer, Director
  • Lori L. Lyons-Williams · Executive Officer
  • Luis C. Pena · Executive Officer
  • Thomas G. Wiggans · Executive Officer, Director
  • David E. Cohen · Director
  • Fred B. Craves · Director
  • Jake R. Nunn · Director
  • Kathleen R. Sebelius · Director
  • Mark D. McDade · Director
  • Matthew K. Fust · Director
  • William R. Ringo · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andrew Guggenhime, Cfo. Source: SEC Form D, newest notice filed Dec 31, 2018. Read the notice at the SEC.

equitySEC
Aug 2016$2 MNo. 4Under $2 million

Dermira, Inc.: Raise no. 4, Aug 2016

Investors in this round

1 investor had bought by the notice of Sep 12, 2016: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Dermira, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew R. Guggenhime · Executive Officer
  • Christopher R. Griffith · Executive Officer
  • Eugene A. Bauer · Executive Officer, Director
  • Luis R. Pena · Executive Officer
  • Thomas G. Wiggans · Executive Officer, Director
  • David E. Cohen · Director
  • Fred E. Craves · Director
  • Jason Raleigh Nunn · Director
  • Kathleen R. Sebelius · Director
  • Mark E. Mcdade · Director
  • Matthew E. Fust · Director
  • William R. Ringo · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andrew Guggenhime, COO and CFO. Source: SEC Form D, newest notice filed Sep 12, 2016. Read the notice at the SEC.

equitySEC
Aug 2014$51 MNo. 3$50 to $250 million

Dermira, Inc.: Raise no. 3, Aug 2014

Investors in this round

15 investors had bought by the notice of Sep 30, 2014: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Dermira, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$51 M of $51 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$1,950,345
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew L. Guggenhime · Executive Officer
  • Christopher M. Griffith · Executive Officer, Promoter
  • Eugene A. Bauer · Executive Officer, Director, Promoter
  • Luis C. Pena · Executive Officer, Promoter
  • Thomas G. Wiggans · Executive Officer, Director, Promoter
  • David E. Cohen · Director
  • Fred B. Craves · Director
  • Jake R. Nunn · Director
  • Mark D. McDade · Director
  • Matthew K. Fust · Director
  • Wende S. Hutton · Director
  • William R. Ringo · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Leerink Partners LLC (CRD 39011) · Boston, MassachusettsSold in MA, MD, NY

Signed by Thomas G.Wiggans, President & CEO. Source: SEC Form D, newest notice filed Sep 30, 2014. Read the notice at the SEC.

equitySEC
Mar 2013$25 MNo. 2$10 to $50 million

Dermira, Inc.: Raise no. 2, Mar 2013

Investors in this round

5 investors had bought by the notice of Jun 13, 2013: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Dermira, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$25 M of $25 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eugene Bauer · Executive Officer, Director, Promoter
  • Thomas Wiggans · Executive Officer, Director, Promoter
  • Fred Craves · Director
  • Jake Nunn · Director
  • Wende Hutton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Thomas Wiggans, President and CEO. Source: SEC Form D, newest notice filed Jun 13, 2013. Read the notice at the SEC.

equitySEC
Aug 2011$34 MNo. 1$10 to $50 million

Dermira, Inc.: Raise no. 1, Aug 2011

Investors in this round

7 investors had bought by the notice of Sep 12, 2012: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Dermira, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$34 M of $42 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eugene Bauer · Executive Officer, Director, Promoter
  • Thomas Wiggans · Executive Officer, Director, Promoter
  • Fred Craves · Director
  • Jake Nunn · Director
  • Wende Hutton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Thomas Wiggans, President and CEO. Source: SEC Form D, newest notice filed Sep 12, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Dermira, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2018).

    SEC Form D · Dec 2018

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2018

That is all the official record says: Dermira, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: its website does not allow automated readers.

Investors#

9 named in official filings. Open an investor to see everything it has backed.

Investors in Dermira, Inc.
InvestorKindAmountRoundRoleSource
Bay City Capital Fund V Co-Investment Fund, L.P.Fund or asset managernot statednot statedHeld Series A, B and C preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Bay City Capital Fund V, L.P.Fund or asset managernot statednot statedHeld Series A, B and C preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Bay City Capital LLCFund or asset managernot statednot statedHeld Series A, B and C preferred stock, 10% owner, director (Form 3, 2014)SEC Form 3
Bay City Capital Management V LLCFund or asset managernot statednot statedHeld Series A, B and C preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Canaan Partners VIII LLCFund or asset managernot statednot statedHeld Series A, B and C preferred stock, 10% owner, director (Form 3, 2014)SEC Form 3
Canaan VIII LPFund or asset managernot statednot statedHeld Series A, B and C preferred stock, 10% owner, director (Form 3, 2014)SEC Form 3
NEA 13 GP, LtdCompanynot statednot statedHeld Series A, B and C preferred stock, 10% owner (Form 3, 2014)SEC Form 3
NEA Partners 13, Limited PartnershipFund or asset managernot statednot statedHeld Series A, B and C preferred stock, 10% owner (Form 3, 2014)SEC Form 3
New Enterprise Associates 13 LPFund or asset managernot statednot statedHeld Series A, B and C preferred stock, 10% owner (Form 3, 2014)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 15 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Dermira, Inc.
NameRoleNamed in
Andrew L. GuggenhimeExecutive officerDec 2018
Christopher M. GriffithExecutive officerDec 2018
Christopher R. HoranExecutive officerDec 2018
Eugene A. BauerExecutive officerDec 2018
Lori L. Lyons-WilliamsExecutive officerDec 2018
Luis C. PenaExecutive officerDec 2018
Thomas G. WiggansExecutive officerDec 2018
Andrew R. GuggenhimeExecutive officerSep 2016
Christopher R. GriffithExecutive officerSep 2016
Luis R. PenaExecutive officerSep 2016
Eugene BauerExecutive officerJun 2013
Thomas WiggansExecutive officerJun 2013
David E. CohenDirectorDec 2018
Eugene A. BauerDirectorDec 2018
Fred B. CravesDirectorDec 2018
Jake R. NunnDirectorDec 2018
Kathleen R. SebeliusDirectorDec 2018
Mark D. McDadeDirectorDec 2018
Matthew K. FustDirectorDec 2018
Thomas G. WiggansDirectorDec 2018
William R. RingoDirectorDec 2018
Fred E. CravesDirectorSep 2016
Jason Raleigh NunnDirectorSep 2016
Mark E. McdadeDirectorSep 2016
Matthew E. FustDirectorSep 2016
Wende S. HuttonDirectorSep 2014
Eugene BauerDirectorJun 2013
Fred CravesDirectorJun 2013
Jake NunnDirectorJun 2013
Thomas WiggansDirectorJun 2013
Wende HuttonDirectorJun 2013
Christopher M. GriffithPromoterSep 2014
Eugene A. BauerPromoterSep 2014
Luis C. PenaPromoterSep 2014
Thomas G. WiggansPromoterSep 2014
Eugene BauerPromoterJun 2013
Thomas WiggansPromoterJun 2013

About

Company in Menlo Park, United States.